Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-29 | Mark Gold, M.D., Director (Age 69) Dr. Gold has served as a member of our Board of Directors since September 30, 2011 and AC’s board of directors since July 2007. From 1990 until his retirement in June 2014, Dr. Gold was a Professor at the University of Florida College of Medicine’s McKnight Brain Institute and was recognized as a Distinguished Professor and Eminent Scholar and was Chairman of the Department of Psychiatry. He has also been recognized as the 17th University of Florida Distinguished Alumni Professor. Dr. Gold taught neuroanatomy and medical neuroscience for four decades and has been a pioneer in translational neuroscience research. He has been a consultant and senior advisor to banks and private equity and venture capital firms on medical devices, pharmaceuticals and health care services throughout his career. Dr. Gold was also a Founding Director of the Somerset Valley Bank and Somerset Valley Financial (Nasdaq: SVBF) from 1991 to 1999 which was sold to Fulton Financial Corporation. Dr. Gold is a Director of The Magstim Company Ltd., a United Kingdom based global leader in brain stimulation, nerve modulation, and intraoperative nerve monitoring and Viewray, a public commercial stage MR-Guided Radiotherapy company specializing in Cancer treatment. Dr. Gold is also Chairman of the Scientific Advisory Board of RiverMendHealth. Dr. Gold’s qualifications to serve on our Board of Directors include his expertise in medical neuroscience and technology, in-depth knowledge of the pharmaceutical industry, and extensive experience in business and management. |
| 2019-06-27 | Mark Gold, M.D., Director (Age 70) Dr. Gold has served as a member of our Board of Directors since September 30, 2011 ... Messrs. Rudelius (Chairman), Blackford and Levine and Dr. Gold are the members of the Audit Committee. Messrs. Neels (Chairman) and Rudelius, Ms. Wendell and Dr. Gold are members of the Compensation Committee. Dr. Gold (Chairman) and Messrs. Levine and Neels and Ms. Wendell are members of the Governance and Nominating Committee. |
| 2020-04-17 | Messrs. Blackford (Chairman), Levine and Rudelius and Dr. Gold are members of the Audit Committee. Messrs. Neels (Chairman), Blackford and Rudelius, and Ms. Wendell are members of the Compensation Committee. Ms. Wendell (Chairman), Mr. Neels and Dr. Gold are members of the Governance, Nominating and Sustainability Committee. Dr. Gold (Chairman), Messrs. Freitag and Levine are members of the Science and Technology Committee. |
| 2021-03-31 | Mark Gold, M.D., Director (Age 72) Dr. Gold has served as a member of our Board of Directors since September 30, 2011. ... Messrs. Blackford (Chairman), and Levine and Dr. Gold are members of the Audit Committee. ... The following table sets forth information concerning the compensation of our non-employee directors during the year ended December 31, 2020. ... Mark Gold, M.D. 58,500 cash fees, 60,002 stock awards, 60,000 option awards, total 178,502. |
| 2022-04-14 | Mark Gold, M.D., Director (Age 73) Dr. Gold has served as a member of our Board of Directors since September 30, 2011, and Axogen Corporation’s board of directors since July 2007. ... Messrs. Johnson (Chairman), and Levine and Ms. Wendell and Dr. Gold are members of the Audit Committee. ... Messrs. Johnson (Chairman) and Freitag and Dr. Gold are members of the Quality, Compliance and Portfolio Management Committee. |
Data sourced from SEC filings. Last updated: 2025-12-07